SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-11-014919
Filing Date
2011-03-16
Accepted
2011-03-16 17:14:52
Documents
3
Period of Report
2011-03-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-7830_18k.htm 8-K 28648
2 EX-99.1 a11-7830_1ex99d1.htm EX-99.1 17661
3 GRAPHIC g78301mmi001.jpg GRAPHIC 5368
  Complete submission text file 0001104659-11-014919.txt   55087
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 11692769
SIC: 2836 Biological Products, (No Diagnostic Substances)